Showing results (1821-1830 of 1,900) with videos related to

Sort By:
Pageof 190
Digestion|August 15, 2012
Recognition of endoscopic diagnosis in differentiated-type early gastric cancer by flexible spectral imaging color enhancement with indigo carmineO Dohi, N Yagi, T Wada, et al.
Brain Research|February 14, 1997
Abeta1-40 but not Abeta1-42 levels in cortex correlate with apolipoprotein E epsilon4 allele dosage in sporadic Alzheimer's diseaseK Ishii, A Tamaoka, H Mizusawa, et al.
Journal of Dental Research|November 10, 2010
FGF-2 stimulates periodontal regeneration: results of a multi-center randomized clinical trialM Kitamura, M Akamatsu, M Machigashira, et al.
Journal of Neurochemistry|August 30, 2016
Chronic consumption of Annona muricata juice triggers and aggravates cerebral tau phosphorylation in wild-type and MAPT transgenic miceRobert Rottscholl, Marlen Haegele, Britta Jainsch, et al.
Clinical and Diagnostic Laboratory Immunology|September 3, 1999
Detection of borna disease virus-reactive antibodies from patients with psychiatric disorders and from horses by electrochemiluminescence immunoassayK Yamaguchi, T Sawada, T Naraki, et al.
Cancer Gene Therapy|January 28, 2012
Antitumor efficacy of oncolytic herpes simplex virus adsorbed onto antigen-specific lymphocytesA Kanzaki, H Kasuya, K Yamamura, et al.
The British Journal of Surgery|July 9, 2020
Phase I/II study of adding intraperitoneal paclitaxel in patients with pancreatic cancer and peritoneal metastasisS Yamada, T Fujii, T Yamamoto, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 20, 2007
Annonacin, a natural mitochondrial complex I inhibitor, causes tau pathology in cultured neuronsMyriam Escobar-Khondiker, Matthias Höllerhage, Marie-Paule Muriel, et al.
The Journal of Cell Biology|September 11, 2013
M2-like macrophages are responsible for collagen degradation through a mannose receptor-mediated pathwayDaniel H Madsen, Daniel Leonard, Andrius Masedunskas, et al.
Bone Marrow Transplantation|November 13, 2001
Long-term low-dose acyclovir against varicella-zoster virus reactivation after allogeneic hematopoietic stem cell transplantationY Kanda, S Mineishi, T Saito, et al.
Pageof 190